FDA created the Rare Disease Innovation Hub (the Hub) to serve as a point of collaboration and connectivity between CBER and CDER with the goal of ultimately improving outcomes for patients.
Similar Posts
Guidance Documents for Rare Disease Drug Development
Guidance Documents for Rare Disease Drug DevelopmentDixon Investments Inc. dba ARI – 710087 – 09/17/2025
CGMP/Finished Pharmaceuticals/AdulteratedSCA Pharmaceuticals Inc. Little Rock, AR. 483 issued 10/30/2025
Task Description Request Please post to the OII FOIA Electronic Reading Room
Record Date 10/30/2025
Short Title (70 char) SCA Pharmaceuticals Inc. Little Rock, AR. 483 issued 10/30/2025
FEI Number 3010683157
Firm Name SCA Pharmaceuticals Inc
Record Type 483
State AR
Establishment Type Outsourcing FaPhysicochemical and Structural (Q3) Characterization of Topical Drug Products Submitted in ANDAs
Physicochemical and Structural (Q3) Characterization of Topical Drug Products Submitted in ANDAsSun Pharmaceutical Industries Ltd. – 6/13/2025
Sun Pharmaceutical Industries Ltd. Country: India. Record Type: 483Lipari Foods Issues Allergy Alert on Undeclared Milk in “Dark Chocolate Nonpareils”
Lipari Foods of Warren, MI, is recalling its 14-ounce packages of JLM Branded “Dark Chocolate Nonpareils” food treats because they may contain undeclared milk. People who have allergies to milk run the risk of serious or life-threatening allergic reaction if they consume these products.